Clinical trial
Short-course Hypofractionated Online-adaptive Radiotherapy for the Treatment of ENdometrial Cancer
NCT07675733 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short-course Hypofractionated Online-adaptive Radiotherapy for the Treatment of ENdometrial Cancer
- Lead sponsor
- Royal Marsden NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- May 31, 2030
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial carcinoma (ec)